{"id":10066,"date":"2019-02-06T10:17:15","date_gmt":"2019-02-06T09:17:15","guid":{"rendered":"https:\/\/www.umweltperspektiven.ch\/?p=1997"},"modified":"2022-02-09T11:10:08","modified_gmt":"2022-02-09T10:10:08","slug":"neuer-fonds-im-namen-der-onkologie-forschung","status":"publish","type":"post","link":"https:\/\/www.organisator.ch\/fr\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","title":{"rendered":"Un nouveau fonds au nom de la recherche en oncologie"},"content":{"rendered":"<figure id=\"attachment_1999\" aria-describedby=\"caption-attachment-1999\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1999 size-medium\" src=\"\/\/www.umweltperspektiven.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven.jpg\" alt=\"\" width=\"680\" height=\"850\" \/><figcaption id=\"caption-attachment-1999\" class=\"wp-caption-text\">Rudi Van den Eynde, Head of Thematic Equity chez Candriam. (Image : zVg)<\/figcaption><\/figure>\n<p>Le fonds Candriam (LU1864481467) investit dans des soci\u00e9t\u00e9s cot\u00e9es en bourse qui d\u00e9veloppent des produits et des services pour le diagnostic et le traitement du cancer. La science a fait quelques progr\u00e8s dans le domaine de l'oncologie, mais les perspectives pour les patients atteints de cancer sont encore souvent mauvaises. Le cancer est la deuxi\u00e8me cause de mortalit\u00e9 dans le monde. Statistiquement, 40 % des hommes et des femmes re\u00e7oivent un diagnostic de cancer \u00e0 un moment ou \u00e0 un autre de leur vie. D'ici 2030, le nombre de d\u00e9c\u00e8s par cancer dans le monde devrait augmenter de 60 %, passant de 8 \u00e0 13 millions par an (voir source 2).<\/p>\n<p><strong>Des innovations m\u00e9dicales porteuses d'espoir <\/strong><br \/>\nImmunoth\u00e9rapie, th\u00e9rapie cibl\u00e9e, biopsie liquide, s\u00e9quen\u00e7age du g\u00e9nome tumoral, nanotechnologie, interventions chirurgicales robotis\u00e9es, intelligence artificielle et big data : chaque jour, les avanc\u00e9es m\u00e9dicales donnent un nouvel espoir aux patients atteints de cancer et \u00e0 leurs familles. Mais les innovations dans le traitement du cancer ont \u00e9galement un impact sur de nombreux autres secteurs, tels que la biotechnologie, la pharmacie, l'intelligence artificielle et la recherche, ainsi que sur les entreprises du monde entier.<\/p>\n<p>Candriam Equities L Oncology Impact soutient le d\u00e9veloppement de nombreuses nouvelles approches pour le diagnostic et le traitement du cancer. L'objectif est d'investir dans des innovations de pointe qui am\u00e9liorent consid\u00e9rablement le traitement de la maladie.<\/p>\n<p>Rudi Van den Eynde, Head of Thematic Equity chez Candriam, d\u00e9clare : \"De nombreux progr\u00e8s ont \u00e9t\u00e9 r\u00e9alis\u00e9s dans le traitement de nombreuses maladies, en particulier dans le traitement du cancer. Nous voulons investir dans des entreprises \u00e0 fort potentiel de croissance. Gr\u00e2ce \u00e0 nos comp\u00e9tences et \u00e0 nos vingt ans d'exp\u00e9rience dans la gestion d'un fonds de biotechnologie, nous sommes tr\u00e8s bien plac\u00e9s pour le faire. L'\u00e9quipe comprend deux analystes titulaires d'un doctorat et est soutenue par un groupe consultatif ind\u00e9pendant compos\u00e9 d'\u00e9minents chercheurs en canc\u00e9rologie\".<\/p>\n<p><strong>Un b\u00e9n\u00e9fice social \u00e9lev\u00e9 est attendu<\/strong><\/p>\n<p>Vincent Hamelink, Chief Investment Officer of Investment Management, ajoute : \"Les nouveaux traitements et les technologies innovantes vont continuer \u00e0 faire cro\u00eetre le march\u00e9 international de l'oncologie. Notre nouveau fonds Candriam Equities L Oncology Impact vise \u00e0 g\u00e9n\u00e9rer des revenus pour les investisseurs tout en soutenant la recherche sur le cancer et en apportant ainsi des avantages sociaux importants. En nous engageant davantage dans ce domaine et en faisant \u00e9galement don de 10 % des frais de gestion du fonds, nous voulons participer directement \u00e0 la lutte contre le cancer\".<\/p>\n<p>Candriam Equities L Oncology Impact est un compartiment de Candriam Equities L, une SICAV (Soci\u00e9t\u00e9 d'investissement \u00e0 capital variable) luxembourgeoise g\u00e9r\u00e9e par Candriam Luxembourg. Le fonds est actuellement autoris\u00e9 \u00e0 la distribution dans les pays suivants : Allemagne, France, Grande-Bretagne, Italie, Luxembourg, Autriche, Pays-Bas, Portugal, Suisse et Espagne. Candriam, le gestionnaire d'actifs europ\u00e9en innovant, g\u00e8re d\u00e9j\u00e0 plus de trois milliards d'euros d'actifs dans ses strat\u00e9gies de biotechnologie, de robotique et de d\u00e9mographie.<\/p>\n<p><a href=\"\/\/www.candriam.com\">www.candriam.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><em>2 Sources : Institut national de la sant\u00e9 (NIH) et Organisation mondiale de la sant\u00e9 (OMS)<\/em><\/p>\n<p><em>Remarque g\u00e9n\u00e9rale : Afin de bien comprendre le profil de risque du fonds, Candriam recommande aux investisseurs de lire attentivement le prospectus officiel et la description des risques. Le prospectus, les derniers rapports annuel et semestriel ainsi que d'autres informations importantes relatives au fonds sont disponibles en anglais ou dans la langue des pays dans lesquels le fonds est autoris\u00e9 \u00e0 la commercialisation.\u00a0<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Der Candriam Fonds (LU1864481467) investiert in b\u00f6rsennotierte Unternehmen, die Produkte und Dienstleistungen zur Diagnose und Behandlung von Krebs entwickeln. Die Wissenschaft hat in der Onkologie einige Fortschritte erzielt, gleichwohl sind die Aussichten f\u00fcr Krebspatienten oft immer noch schlecht. Krebs ist die weltweit zweith\u00e4ufigste Todesursache. Statistisch gesehen erhalten 40 Prozent aller M\u00e4nner und Frauen irgendwann in [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":9583,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"Candriam","_yoast_wpseo_metadesc":"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.","articlekey":"","footnotes":""},"categories":[580],"tags":[1206,274,1442,1679,1873],"class_list":["post-10066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sustainability","tag-fonds","tag-innovation","tag-investment","tag-medizin","tag-onkologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuer Fonds im Namen der Onkologie-Forschung - Organisator<\/title>\n<meta name=\"description\" content=\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.organisator.ch\/fr\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuer Fonds im Namen der Onkologie-Forschung - Organisator\" \/>\n<meta property=\"og:description\" content=\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.organisator.ch\/fr\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/\" \/>\n<meta property=\"og:site_name\" content=\"Organisator\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OrganisatorFachmagazin\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-06T09:17:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-09T10:10:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2047\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"michael.merz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"},\"author\":{\"name\":\"michael.merz\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/134708ca9321c57b0362cceb7948ffbd\"},\"headline\":\"Neuer Fonds im Namen der Onkologie-Forschung\",\"datePublished\":\"2019-02-06T09:17:15+00:00\",\"dateModified\":\"2022-02-09T10:10:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"},\"wordCount\":508,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"keywords\":[\"Fonds\",\"Innovation\",\"Investment\",\"Medizin\",\"Onkologie\"],\"articleSection\":[\"SUSTAINABILITY\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\",\"name\":\"Neuer Fonds im Namen der Onkologie-Forschung - Organisator\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"datePublished\":\"2019-02-06T09:17:15+00:00\",\"dateModified\":\"2022-02-09T10:10:08+00:00\",\"description\":\"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg\",\"width\":2047,\"height\":2560,\"caption\":\"Rudi Van den Eynde, Head of Thematic Equity bei Candriam. (Bild: zVg)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/sustainability\\\/2019-02-06\\\/neuer-fonds-im-namen-der-onkologie-forschung\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.organisator.ch\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuer Fonds im Namen der Onkologie-Forschung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"name\":\"Organisator\",\"description\":\"Kompetent. Praxisnah. Der ORGANISATOR bereitet in 10 Ausgaben pro Jahr die wesentlichen Themen f\u00fcr F\u00fchrungskr\u00e4fte von KMU auf.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.organisator.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\",\"name\":\"Organisator\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"width\":800,\"height\":77,\"caption\":\"Organisator\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/OrganisatorFachmagazin\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/organisator-das-magazin-fr-kmu\",\"https:\\\/\\\/www.xing.com\\\/news\\\/pages\\\/organisator-ch-695\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCGP2Sq0iWaZwT3BdIAQFYpw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/134708ca9321c57b0362cceb7948ffbd\",\"name\":\"michael.merz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"michael.merz\"},\"url\":\"https:\\\/\\\/www.organisator.ch\\\/fr\\\/author\\\/michael-merz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouveau fonds au nom de la recherche en oncologie - Organisateur","description":"Candriam a annonc\u00e9 le lancement du fonds d'actions th\u00e9matique Candriam Equities L Oncology Impact \u00e0 l'occasion de la Journ\u00e9e mondiale contre le cancer 2019.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.organisator.ch\/fr\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","og_locale":"fr_FR","og_type":"article","og_title":"Neuer Fonds im Namen der Onkologie-Forschung - Organisator","og_description":"Candriam hat zum Weltkrebstag 2019 die Auflage des thematischen Aktienfonds Candriam Equities L Oncology Impact bekannt gegeben.","og_url":"https:\/\/www.organisator.ch\/fr\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","og_site_name":"Organisator","article_publisher":"https:\/\/www.facebook.com\/OrganisatorFachmagazin","article_published_time":"2019-02-06T09:17:15+00:00","article_modified_time":"2022-02-09T10:10:08+00:00","og_image":[{"width":2047,"height":2560,"url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","type":"image\/jpeg"}],"author":"michael.merz","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#article","isPartOf":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"},"author":{"name":"michael.merz","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/134708ca9321c57b0362cceb7948ffbd"},"headline":"Neuer Fonds im Namen der Onkologie-Forschung","datePublished":"2019-02-06T09:17:15+00:00","dateModified":"2022-02-09T10:10:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"},"wordCount":508,"commentCount":0,"publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"image":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","keywords":["Fonds","Innovation","Investment","Medizin","Onkologie"],"articleSection":["SUSTAINABILITY"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","url":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/","name":"Nouveau fonds au nom de la recherche en oncologie - Organisateur","isPartOf":{"@id":"https:\/\/www.organisator.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"image":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","datePublished":"2019-02-06T09:17:15+00:00","dateModified":"2022-02-09T10:10:08+00:00","description":"Candriam a annonc\u00e9 le lancement du fonds d'actions th\u00e9matique Candriam Equities L Oncology Impact \u00e0 l'occasion de la Journ\u00e9e mondiale contre le cancer 2019.","breadcrumb":{"@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#primaryimage","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2019\/02\/Candriam_Rudi_Vandeneynde_UP_Umweltperspektiven-scaled.jpg","width":2047,"height":2560,"caption":"Rudi Van den Eynde, Head of Thematic Equity bei Candriam. (Bild: zVg)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.organisator.ch\/sustainability\/2019-02-06\/neuer-fonds-im-namen-der-onkologie-forschung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.organisator.ch\/"},{"@type":"ListItem","position":2,"name":"Neuer Fonds im Namen der Onkologie-Forschung"}]},{"@type":"WebSite","@id":"https:\/\/www.organisator.ch\/#website","url":"https:\/\/www.organisator.ch\/","name":"Organisateur","description":"Comp\u00e9tence et comp\u00e9tence. Proches de la pratique. L'ORGANISATEUR pr\u00e9pare 10 num\u00e9ros par an sur les th\u00e8mes essentiels pour les dirigeants de PME.","publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.organisator.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.organisator.ch\/#organization","name":"Organisateur","url":"https:\/\/www.organisator.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","width":800,"height":77,"caption":"Organisator"},"image":{"@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OrganisatorFachmagazin","https:\/\/www.linkedin.com\/showcase\/organisator-das-magazin-fr-kmu","https:\/\/www.xing.com\/news\/pages\/organisator-ch-695","https:\/\/www.youtube.com\/channel\/UCGP2Sq0iWaZwT3BdIAQFYpw"]},{"@type":"Person","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/134708ca9321c57b0362cceb7948ffbd","name":"michael.merz","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"michael.merz"},"url":"https:\/\/www.organisator.ch\/fr\/author\/michael-merz\/"}]}},"_links":{"self":[{"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/posts\/10066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/comments?post=10066"}],"version-history":[{"count":1,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/posts\/10066\/revisions"}],"predecessor-version":[{"id":10911,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/posts\/10066\/revisions\/10911"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/media\/9583"}],"wp:attachment":[{"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/media?parent=10066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/categories?post=10066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.organisator.ch\/fr\/wp-json\/wp\/v2\/tags?post=10066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}